» Articles » PMID: 15784876

Inhibitors of Ocular Neovascularization: Promises and Potential Problems

Overview
Journal JAMA
Specialty General Medicine
Date 2005 Mar 24
PMID 15784876
Citations 69
Authors
Affiliations
Soon will be listed here.
Citing Articles

Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy.

Lei Y, Liu Q, Chen B, Wu F, Li Y, Dong X Nat Commun. 2024; 15(1):9334.

PMID: 39472558 PMC: 11522279. DOI: 10.1038/s41467-024-53601-x.


Efficacy and safety of intravitreal injections of conbercept for the treatment of idiopathic choroidal neovascularization.

Zhai G, Su Y, Wang S, Lu H, Liu N BMC Ophthalmol. 2024; 24(1):75.

PMID: 38373901 PMC: 10875827. DOI: 10.1186/s12886-024-03344-6.


Comparative Efficacy of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents and Corticosteroids in Managing Diabetic Retinopathy-Associated Diabetic Macular Edema: A Meta-Analysis and Comprehensive Systematic Review.

Kumar A, Kumar A, Kumar J, Bai G, Jeewnani R, Dembra M Cureus. 2024; 16(1):e51910.

PMID: 38333510 PMC: 10850611. DOI: 10.7759/cureus.51910.


Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report.

Nur-Najwa S, Zunaina E, Azhany Y Cureus. 2023; 15(8):e44420.

PMID: 37791179 PMC: 10543730. DOI: 10.7759/cureus.44420.


The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.

Mi X, Gu X, Yu X Trials. 2022; 23(1):736.

PMID: 36056443 PMC: 9438173. DOI: 10.1186/s13063-022-06593-2.